isoborneol has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borisevich, SS; Gureev, MA; Khamitov, EM; Maksyutov, RA; Mordvinova, ED; Pyankov, OV; Rogachev, AD; Rudometova, NB; Salakhutdinov, NF; Shcherbakov, DN; Sokolova, AS; Yarovaya, OI; Zaykovskaya, AV; Zybkina, AV | 1 |
1 other study(ies) available for isoborneol and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Borneol Ester Derivatives as Entry Inhibitors of a Wide Spectrum of SARS-CoV-2 Viruses.
Topics: Antiviral Agents; Camphanes; COVID-19; Esters; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2022 |